Robust Evidence Generation & Value Demonstration Activities to Support Commercialization
Time: 2:00 pm
day: Conference Day Two
Details:
- Boosting the value proposition of commercial therapies through real-world evidence (RWE) and publications
- Navigating guidance on incorporating RWE into regulatory and HTA submissions
- Key considerations when working on commercial programmes with payer uncertainty over durability and therapeutic benefit
